A mini-review of c-Met as a potential therapeutic target in melanoma
- 1 April 2017
- journal article
- review article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 88, 194-202
Abstract
No abstract availableKeywords
This publication has 82 references indexed in Scilit:
- Epithelial-mesenchymal transitions: insights from developmentDevelopment, 2012
- Resistance patterns with tyrosine kinase inhibitors in melanomaCurrent Opinion in Oncology, 2012
- MET signalling: principles and functions in development, organ regeneration and cancerNature Reviews Molecular Cell Biology, 2010
- The biological role of HGF-MET axis in tumor growth and development of metastasisFrontiers in Bioscience-Landmark, 2008
- BRAFE600 in benign and malignant human tumoursOncogene, 2007
- RaLP, a New Member of the Src Homology and Collagen Family, Regulates Cell Migration and Tumor Growth of Metastatic MelanomasCancer Research, 2007
- Therapeutic targeting of receptor tyrosine kinases in lung cancerExpert Opinion on Therapeutic Targets, 2005
- Geographical Variation in the Penetrance of CDKN2A Mutations for MelanomaJNCI: Journal of the National Cancer Institute, 2002
- Scatter-factor and semaphorin receptors: cell signalling for invasive growthNature Reviews Cancer, 2002
- Proteolytic processing of the hepatocyte growth factor/scatter factor receptor by furinFEBS Letters, 1993